Skip to main content
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.
Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.
Targeting oncogenic Ras signaling in hematologic malignancies.
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.
Advancing the STATus of MPN pathogenesis.
Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.